NCT01874600

Brief Summary

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
239

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 11, 2013

Completed
20 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

July 10, 2019

Status Verified

July 1, 2019

Enrollment Period

6.4 years

First QC Date

June 5, 2013

Last Update Submit

July 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.

    The primary objective of the research is to determine the ability of the Brain Sentinel Seizure Detection System to accurately detect GTC seizures in comparison to the recognized "gold standard" for seizure detection, video Electroencephalography (vEEG).The primary endpoint will be the sensitivity of GTC seizure detection (defined as within 30 seconds of motor manifestation via vEEG analysis) in a hospital setting.

    less than 1 month

Secondary Outcomes (1)

  • Comparison of study device to self reporting of seizures using a seizure diary.

    Less than 1 month

Study Arms (1)

Epilepsy Patients

This study will compare accuracy of seizure detection by the study device to simultaneously collected data of seizure detection by video EEG.

Device: Brain Sentinel Seizure Detection Device and Warning System

Interventions

The Brain Sentinel Seizure Detection Device and Warning System is designed to monitor Epilepsy patients and alerts caregivers that a GTC seizure is occurring

Epilepsy Patients

Eligibility Criteria

Age13 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Adolescent epilepsy patients with a history of generalized tonic-clonic seizures either primary GTC or partial onset seizures with second generalization.

You may qualify if:

  • Subject has a suspected history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization.
  • Is being admitted to a hospital for routine vEEG monitoring related to seizures.
  • Male or female between the ages of 13-21.
  • If female and of childbearing potential, has a negative pregnancy urine test, and must also not be nursing.
  • Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
  • Subject and/or Primary Caregiver must be competent to follow all study procedures.
  • Is able to read, speak, and understand English or has a LAR that does so.
  • Subject/LAR consents to the use of vEEG files, including video/audio recordings, for purposes of this research study.

You may not qualify if:

  • Has not had a GTC seizure within the last year AND is not expected to have a reduction of anti-epileptic drugs during their hospital admission.
  • Intracranial EEG electrodes are being used.
  • The subject is allergic to adhesives or any component of the electrode patch assembly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brain Sentinel

San Antonio, Texas, 78232-1399, United States

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jose' E Cavazos, MD, PhD

    Brain Sentinel

    PRINCIPAL INVESTIGATOR
  • Dennis Dlugos, MD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR
  • Jonathan Halford, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR
  • Dileep Nair, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2013

First Posted

June 11, 2013

Study Start

July 1, 2013

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

July 10, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations